L&C BIO Co.,LTD (KOSDAQ:290650)
94,200
+5,900 (6.68%)
Jun 29, 2026, 3:30 PM KST
238.24% (1Y)
| Market Cap | 2.54T +295.7% |
| Revenue (ttm) | 98.10B +34.1% |
| Net Income | -135.14B |
| EPS | -5,627.49 |
| Shares Out | 26.97M |
| PE Ratio | n/a |
| Forward PE | 79.36 |
| Dividend | 50.00 (0.06%) |
| Ex-Dividend Date | Dec 29, 2025 |
| Volume | 385,378 |
| Open | 88,800 |
| Previous Close | 88,300 |
| Day's Range | 88,300 - 97,000 |
| 52-Week Range | 26,400 - 125,000 |
| Beta | 1.38 |
| Analysts | Buy |
| Price Target | 95,000.00 (+0.85%) |
| Earnings Date | Aug 14, 2026 |